• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC PUERTO RICO OPERATIONS CO. INTERSTIM X; STIMULATOR, ELECTRICAL, IMPLANTABLE, FOR INCON

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC PUERTO RICO OPERATIONS CO. INTERSTIM X; STIMULATOR, ELECTRICAL, IMPLANTABLE, FOR INCON Back to Search Results
Model Number 97800
Device Problem Energy Output Problem (1431)
Patient Problems Pain (1994); Urinary Frequency (2275); Discomfort (2330); Hematuria (2558); Insufficient Information (4580)
Event Date 10/23/2023
Event Type  malfunction  
Manufacturer Narrative
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Information was received from a patient who was implanted with an implantable neurostimulator (ins) for urinary/bowel dysfunction.It was reported that since received this implant on (b)(6) 2023 has experienced a lot of discomfort right at the neurostimulator site.Patient said that last month was in severe pain and saw their urology surgeon.Patient also said that noticed blood in the urine and a culture was ran which came up negative.Patient said turned stimulation off about two weeks ago.Patient also said was urinating all of the time since turned stimulation off.Patient said that the blood in the urine stopped and the pain at the neurostimulator site has also stopped.Patient said that their urologist's office redirected patient to contact medtronic for direction.Later in the call asked about any changes and patient said that around the first of the year they stopped taking bladder medication, gemtesa due to insurance reasons.Patient then said that has been taking gemtesa since received this implant and beforehand.When asked, patient said will be restarting gemtesa in a day or two.With instruction patient connected to implant and it was determined that stimulation was on, which means that patient didn't turn therapy off before when they thought they did.Patient then mentioned that turned therapy down.Reviewed general programming guidance and patient made a slight increase in setting.Patient to monitor bladder symptoms however to also pay attention if notices any discomfort at neurostimulator site.Patient to keep stimulation setting the same after restarts bladder medication and wait a few days to determine results with medication.If needed, patient to make slight adjustments to setting and continue to monitor bladder symptoms and whether or not notices any discomfort at neurostimulator site.Suggested patient provide update to urologist.
 
Event Description
Additional information was received from the patient.They reported that the cause of the stimulation being on when it was noted that it was off is unknown.They were experiencing pain where the device was placed and the doctor said it was off.It was when they talked to the manufacturing representative (rep) and was told it was still on, but they had turned it off.The rep went over it with them.They really don't think their device is working as it should because they are still having problems.
 
Manufacturer Narrative
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INTERSTIM X
Type of Device
STIMULATOR, ELECTRICAL, IMPLANTABLE, FOR INCON
Manufacturer (Section D)
MEDTRONIC PUERTO RICO OPERATIONS CO.
road 31, km. 24, hm 4
ceiba norte industrial park
juncos PR 00777
Manufacturer (Section G)
MEDTRONIC PUERTO RICO OPERATIONS CO.
road 31, km. 24, hm 4
ceiba norte industrial park
juncos PR 00777
Manufacturer Contact
glen belmer
7000 central avenue ne rcw215
minneapolis, MN 55432
6122713209
MDR Report Key18883509
MDR Text Key337468921
Report Number3004209178-2024-06835
Device Sequence Number1
Product Code EZW
UDI-Device Identifier00763000484668
UDI-Public00763000484668
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P970004
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date 05/07/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number97800
Device Catalogue Number97800
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 03/06/2024
Initial Date FDA Received03/12/2024
Supplement Dates Manufacturer Received04/17/2024
Supplement Dates FDA Received05/07/2024
Date Device Manufactured06/15/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age85 YR
Patient SexFemale
-
-